R1 RCM Inc

R1 RCM Inc Stock Forecast & Price Prediction

Live R1 RCM Inc Stock (RCM) Price
$14.31

4

Ratings

  • Buy 1
  • Hold 3
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$14.31

P/E Ratio

1,247.00

Volume Traded Today

$0

Dividend

Dividends not available for RCM

52 Week High/low

15.12/8.87

R1 RCM Inc Market Cap

$6.04B

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $RCM ๐Ÿ›‘

Before you buy RCM you'll want to see this list of ten stocks that have huge potential. Want to see if RCM made the cut? Enter your email below

RCM Summary

The R1 RCM Inc (RCM) share price is expected to increase by 8.14% over the next year. This is based on calculating the average 12-month share price estimate provided by 4 stock analysts who have covered RCM. Price targets range from $14.3 at the low end to $19 at the high end. The current analyst consensus for RCM is a buy. Please note analyst price targets are not guaranteed and could be missed completely.

RCM Analyst Ratings

R1 RCM Inc has a total of 4 Wall St Analyst ratings. There are 1 buy ratings, 3 ratings, and 0 sell ratings. Since most analysts have a buy consensus rating, the expectation is that R1 RCM Inc will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.

RCM stock forecast by analyst

These are the latest 20 analyst ratings of RCM.

Analyst/Firm

Rating

Price Target

Change

Date

Sarah James
Cantor Fitzgerald

Neutral

$14.3

Reiterates

Oct 4, 2024
Sarah James
Cantor Fitzgerald

Neutral

$14.3

Reiterates

Aug 20, 2024
Jailendra Singh
Truist Securities

Hold

$14.3

Maintains

Aug 8, 2024
Charles Rhyee
TD Cowen

Hold

$14.3

Downgrade

Aug 5, 2024
Michael Cherny
Leerink Partners

Market Perform

$14.3

Downgrade

Aug 1, 2024
Richard Close
Canaccord Genuity

Buy

$15

Maintains

Jul 22, 2024
George Hill
Deutsche Bank

Hold

$16

Maintains

Jul 9, 2024
Craig Hettenbach
Morgan Stanley

Overweight

$17

Maintains

Jul 8, 2024
Sarah James
Cantor Fitzgerald

Overweight

$20

Reiterates

Jul 2, 2024
Vikram Kesavabhotla
Baird

Outperform

$18

Maintains

Jul 2, 2024
Sean Dodge
RBC Capital

Outperform

$19

Reiterates

Jun 28, 2024
Sean Dodge
RBC Capital

Outperform

$19

Reiterates

Jun 11, 2024
Richard Close
Canaccord Genuity

Buy

$15

Maintains

May 9, 2024
Sarah James
Cantor Fitzgerald

Overweight

$20

Reiterates

Apr 10, 2024
Scott Schoenhaus
Keybanc

Sector Weight


Downgrade

Apr 10, 2024
Jack Wallace
Guggenheim

Buy

$15

Maintains

Apr 5, 2024
Jailendra Singh
Truist Securities

Hold

$16

Maintains

Apr 1, 2024
Craig Hettenbach
Morgan Stanley

Overweight

$17

Reiterates

Mar 26, 2024
Richard Close
Canaccord Genuity

Buy

$16

Maintains

Mar 20, 2024
Daniel Grosslight
Citigroup

Buy

$16

Upgrade

Mar 20, 2024

RCM Company Information

What They Do: Provides financial solutions for healthcare systems.

Business Model: The company generates revenue by offering technology-driven solutions that manage various aspects of the revenue cycle for health systems, hospitals, and physician groups. Its business model includes end-to-end operating partnerships and modular solutions that enhance revenue performance and patient experiences, allowing clients to improve cash collections, optimize revenue, and ensure compliance.

Other Information: Formerly known as Accretive Health, Inc., R1 RCM Inc. rebranded in January 2017. It was incorporated in 2003 and is based in Murray, Utah. As of November 19, 2024, the company was taken private, which may impact its future growth and investment potential.
RCM
R1 RCM Inc (RCM)

When did it IPO

2015

Staff Count

29,400

Country

United States

Sector/Industry

Healthcare/Health Information Services

CEO

Mr. Lee Rivas

Market Cap

$6.04B

R1 RCM Inc (RCM) Financial Data

In 2023, RCM generated $2.25B in revenue, which was a increase of 24.79% from the previous year. This can be seen as a signal that RCM's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

$1.27B

Revenue From 2021

$1.47B

16.10 %
From Previous Year

Revenue From 2022

$1.81B

22.50 %
From Previous Year

Revenue From 2023

$2.25B

24.79 %
From Previous Year
  • Revenue TTM $2.46B
  • Operating Margin TTM 3.8%
  • Gross profit TTM $484.5M
  • Return on assets TTM 2.4%
  • Return on equity TTM -2.2%
  • Profit Margin -2.5%
  • Book Value Per Share 6.66%
  • Market capitalisation $6.04B
  • Revenue for 2021 $1.47B
  • Revenue for 2022 $1.81B
  • Revenue for 2023 $2.25B
  • EPS this year (TTM) $-0.14

R1 RCM Inc (RCM) Latest News

News Image

Thu, 21 Nov 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - Planet DDS, a cloud-based dental practice management provider, reports strong growth in 2024 with new product improvements and partnerships, positioning itself for a record-breaking year.

Why It Matters - Planet DDS's advancements and partnerships signal strong growth potential, likely boosting revenue and market position, which could lead to increased investor confidence and share value.

News Image

Tue, 19 Nov 2024

Sentiment - NEUTRAL

Source - GlobeNewsWire

Summary - R1 RCM has transitioned to a privately held company, with Joe Flanagan being reappointed as CEO.

Why It Matters - R1 RCM's transition to a privately held company may impact its growth strategy and financial transparency, affecting future investment opportunities and valuations.

News Image

Tue, 05 Nov 2024

Sentiment - NEGATIVE

Source - Zacks Investment Research

Summary - R1 RCM Inc. reported a quarterly loss of $0.05 per share, better than the expected loss of $0.15, compared to break-even earnings per share a year earlier.

Why It Matters - R1 RCM's smaller-than-expected loss indicates improving financial performance, potentially boosting investor confidence and affecting stock valuation positively.

News Image

Tue, 05 Nov 2024

Sentiment - POSITIVE

Source - Zacks Investment Research

Summary - R1 RCM INC's Q3 2024 revenue and EPS indicate business performance; investors should compare these metrics with Wall Street estimates and year-ago figures for context.

Why It Matters - Comparing R1 RCM's revenue and EPS to Wall Street estimates and prior year figures provides insights into performance trends and market expectations, influencing investor sentiment and stock valuation.

News Image

Wed, 30 Oct 2024

Sentiment - NEUTRAL

Source - Accesswire

Summary - Levi & Korsinsky, LLP is investigating R1 RCM Inc (NASDAQ: RCM) for potential breaches of fiduciary duties by its board, affecting shareholders who purchased stock before February 23, 2024.

Why It Matters - The investigation into R1 RCM's board may signal potential legal issues or governance concerns, impacting shareholder confidence and stock performance.

News Image

Thu, 31 Oct 2024

Sentiment - NEUTRAL

Source - Accesswire

Summary - Levi & Korsinsky, LLP is investigating R1 Rcm Inc (NASDAQ: RCM) for potential breaches of fiduciary duties by its board, affecting shareholders who bought stock before February 23, 2024.

Why It Matters - The investigation into R1 RCM's board may indicate potential governance issues, impacting stockholder confidence and possibly affecting the company's stock price.

...

RCM Frequently asked questions

The highest forecasted price for RCM is $19 from Michael Cherny at B of A Securities.

The lowest forecasted price for RCM is $14.3 from Michael Cherny from Leerink Partners

The RCM analyst ratings consensus are 1 buy ratings, 3 hold ratings, and 0 sell ratings.